ArticleBMC cancer2024

Combined KRAS and TP53 mutation in patients with colorectal cancer enhance chemoresistance to promote postoperative recurrence and metastasis.

YiMeng Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.